[Antibodies to different virus antigens in patients with chronic hepatitis C]

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|June 9, 2006
PubMed

Insights

Antibody detection in chronic hepatitis C (CHC) patients reveals specific patterns. The presence of anti-NS5 and anti-HCV IgM correlates with higher alanine aminotransferase (ALT) levels and liver cirrhosis in CHC.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Chronic hepatitis C (CHC) is a significant global health concern.
  • Understanding the host immune response to hepatitis C virus (HCV) is crucial for disease management.
  • Antibody profiles can provide insights into viral activity and disease progression.

Purpose of the Study:

  • To investigate the spectrum of antibodies against different hepatitis C virus (HCV) proteins in CHC patients.
  • To explore correlations between antibody detection, patient demographics, and disease severity markers.
  • To assess the diagnostic and prognostic value of specific antibody responses in CHC.

Main Methods:

  • Serological testing for antibodies against HCV core, NS3, NS4, and NS5 proteins.
  • Detection of IgM antibodies to HCV (anti-HCV IgM).
  • Analysis of antibody prevalence in relation to patient age, sex, alanine aminotransferase (ALT) levels, and liver cirrhosis status.

Main Results:

  • Antibodies to core, NS3, and NS4 proteins were simultaneously detected in 92% of CHC patients.
  • Anti-NS4 and anti-NS5 antibodies were less frequent in patients under 20 years old.
  • Higher ALT levels and liver cirrhosis were associated with the presence of anti-NS5 and anti-HCV IgM.
  • Anti-HCV IgM was detected more frequently in females over 60 and in patients with elevated ALT or liver cirrhosis.

Conclusions:

  • The antibody spectrum against HCV proteins varies with age and disease progression.
  • The presence of anti-NS5 and anti-HCV IgM antibodies is linked to increased liver inflammation and fibrosis in CHC.
  • Specific antibody profiles may serve as biomarkers for disease activity and severity in chronic hepatitis C.

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...